A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)

NCT05394064 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class

Stopped The SBT101 program for AMN was terminated for business/strategic reasons, and there were no safety concerns

Conditions

Interventions

Sponsor

SwanBio Therapeutics, Inc.